Search - tctmd.com

Displaying 521 - 540 of 870

Sort: Relevancy | Date

Presentation TCT 2017

When and Which Antiplatelet Agent Should Be Dropped When Using Oral Anticoagulant Therapy?

Presenter: Robert A. Harrington, Kurt Huber, Roxana Mehran

November 01, 2017

Presentation TCT 2017

DECISION-CTO and EURO-CTO: Topline Findings and Practice Implications

Presenter: David J. Cohen, Ajay J. Kirtane, Gerald S. Werner

November 01, 2017

Presentation TCT 2017

Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding

Presenter: Robert A. Harrington, Kurt Huber, Michelle O'Donoghue

November 01, 2017

Presentation TCT 2017

Should the Type of Stent Influence DAPT Decisions in Patients Receiving OAC? Insights From WOEST, LEADERS Free, and More

Presenter: Robert A. Harrington, Kurt Huber, Didier Carrié

November 01, 2017

Presentation TCT 2017

Guidelines and Expert Consensus on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI: How Strong Is the Evidence?

Presenter: Robert A. Harrington, Kurt Huber, Jean-François Tanguay

November 01, 2017

Presentation TCT 2017

What Is (and Is Not) Known About DAPT Decisions in Patients on Chronic Oral Anticoagulants

Presenter: Robert A. Harrington, Kurt Huber, Freek W.A. Verheugt

November 01, 2017

Presentation TCT 2017

The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus Antiplatelet Therapy

Presenter: Robert A. Harrington, Kurt Huber, Renato D. Lopes

November 01, 2017

Presentation TCT 2017

Case #2 Conclusion: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How We Treated

Presenter: David J. Maron, Alan C. Yeung, Vasim Farooq

November 01, 2017

Presentation TCT 2017

Transcatheter Tricuspid Intervention With a Twist

Presenter: A. Pieter Kappetein, Georg Nickenig, Duane S. Pinto

November 01, 2017

Presentation TCT 2017

Case #3 Introduction: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How Should We Treat?

Presenter: David J. Maron, Alan C. Yeung, Vasim Farooq

November 01, 2017

Presentation TCT 2017

MitraClip or TAVR With Left Atrial Appendage Closure

Presenter: A. Pieter Kappetein, Georg Nickenig, Ramon Quesada

November 01, 2017

Presentation TCT 2017

Concomitant Severe Aortic Stenosis and Mitral Regurgitation: Is There a Role for Concurrent Transcatheter Therapy?

Presenter: A. Pieter Kappetein, Georg Nickenig, Joachim Schofer

November 01, 2017

Presentation TCT 2017

Case #2 Introduction: An Asymptomatic Diabetic Patient With Normal Exercise Tolerance and Multivessel Disease How Should We Treat?

Presenter: David J. Maron, Alan C. Yeung, Frederick Feit

November 01, 2017

Presentation TCT 2017

Case #1 Conclusion: A Diabetic Patient With Left Main Disease How We Treated

Presenter: David J. Maron, Alan C. Yeung, Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Concomitant Severe Tricuspid and Mitral Regurgitation: Is There a Role for Concurrent Transcatheter Therapy?

Presenter: A. Pieter Kappetein, Georg Nickenig, Maurizio Taramasso

November 01, 2017

Presentation TCT 2017

No Longer an Interventionalist? Try Something Else

Presenter: Michael J. Rinaldi, David O. Williams, David P. Faxon

November 01, 2017

Presentation TCT 2017

Case #1 Introduction: A Diabetic Patient With Left Main Disease How Should We Treat?

Presenter: David J. Maron, Alan C. Yeung, Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Hemolysis After TMVR

Presenter: Alfredo Trento, David W.M. Muller

November 01, 2017

Presentation TCT 2017

Knowing When and How to Stop

Presenter: Michael J. Rinaldi, David O. Williams, George W. Vetrovec

November 01, 2017

Presentation TCT 2017

The Solution? Ongoing Efforts to Improve Image Quality and Decrease Variability in SHD Diagnosis and Interventions (Guidelines, Training, and More)

Presenter: G. Burkhard Mackensen, Robert J. Siegel

November 01, 2017

Advertisement

When and Which Antiplatelet Agent Should Be Dropped When Using Oral Anticoagulant Therapy?

DECISION-CTO and EURO-CTO: Topline Findings and Practice Implications

Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding

Should the Type of Stent Influence DAPT Decisions in Patients Receiving OAC? Insights From WOEST, LEADERS Free, and More

Guidelines and Expert Consensus on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI: How Strong Is the Evidence?

What Is (and Is Not) Known About DAPT Decisions in Patients on Chronic Oral Anticoagulants

The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus Antiplatelet Therapy

Case #2 Conclusion: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How We Treated

Transcatheter Tricuspid Intervention With a Twist

Case #3 Introduction: A Symptomatic Diabetic Patient With Chronic Kidney Disease and 3-Vessel Disease How Should We Treat?

MitraClip or TAVR With Left Atrial Appendage Closure

Concomitant Severe Aortic Stenosis and Mitral Regurgitation: Is There a Role for Concurrent Transcatheter Therapy?

Case #2 Introduction: An Asymptomatic Diabetic Patient With Normal Exercise Tolerance and Multivessel Disease How Should We Treat?

Case #1 Conclusion: A Diabetic Patient With Left Main Disease How We Treated

Concomitant Severe Tricuspid and Mitral Regurgitation: Is There a Role for Concurrent Transcatheter Therapy?

No Longer an Interventionalist? Try Something Else

Case #1 Introduction: A Diabetic Patient With Left Main Disease How Should We Treat?

Hemolysis After TMVR

Knowing When and How to Stop

The Solution? Ongoing Efforts to Improve Image Quality and Decrease Variability in SHD Diagnosis and Interventions (Guidelines, Training, and More)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content